MBX — MBX Biosciences Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Energy stocks, Primerica, Micron Technology
U.S. STOCKS ON THE MOVE-Clean energy stocks, Energy stocks, McKesson
MBX Biosciences eases after stock offering announced
Brief: Mbx Biosciences Files For Offering Of 10 Million Shares Of Common Stock - SEC Filing
Brief: MBX Biosciences Announces Proposed Public Offering
MBX Biosciences announces equity offering after stock doubles
U.S. STOCKS ON THE MOVE-Iron Mountain, Semler Scientific, Nvidia
U.S. STOCKS ON THE MOVE-GATX, Apple, Tesla
MBX Biosciences surges after mid-stage trial win for hormone disorder drug
U.S. STOCKS ON THE MOVE-Anywhere Real Estate, MBX Biosciences, Ryder System
MBX Biosciences rises after mid-stage trial win for hormone disorder drug
Brief: MBX Biosciences To Provide Topline Results From Its Phase 2 Trial Of Canvuparatide
Brief: Mbx Biosciences Reports Second Quarter 2025 Financial Results And Recent Corporate Highlights
U.S. STOCKS ON THE MOVE- Commvault Systems, Rockwell Automation, Tesla
U.S. STOCKS ON THE MOVE-Commvault Systems, Rockwell Automation, Tesla
U.S. STOCKS ON THE MOVE-Legend Biotech, Unity Software, MP Materials
U.S. STOCKS ON THE MOVE-Johnson & Johnson, Easterly Government Properties, Bank of America
Oppenheimer initiates coverage on MBX Biosciences with 'outperform'
Brief: Mbx Biosciences Appoints Andreas Moraitis, M.D., As Senior Vice President Of Clinical Development